BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiao X, Li J, McCown TJ, Samulski RJ. Gene transfer by adeno-associated virus vectors into the central nervous system. Exp Neurol. 1997;144:113-124. [PMID: 9126160 DOI: 10.1006/exnr.1996.6396] [Cited by in Crossref: 147] [Cited by in F6Publishing: 125] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Lowenstein PR, Southgate TD, Smith-arica JR, Smith J, Castro MG. Chapter 33 Gene therapy for inherited neurological disorders: Towards therapeutic intervention in the Lesch-Nyhan syndrome. Neuronal Degeneration and Regeneration: From Basic Mechanisms to Prospects for Therapy, Proceedings of the 20th International Summer School of Brain Research. Elsevier; 1998. pp. 485-501. [DOI: 10.1016/s0079-6123(08)64034-0] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
2 Virella-lowell I, Zusman B, Foust K, Loiler S, Conlon T, Song S, Chesnut KA, Ferkol T, Flotte TR. Enhancing rAAV vector expression in the lung. J Gene Med 2005;7:842-50. [DOI: 10.1002/jgm.759] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.2] [Reference Citation Analysis]
3 Afarid M, Namvar E, Sanie-Jahromi F. Diabetic Retinopathy and BDNF: A Review on Its Molecular Basis and Clinical Applications. J Ophthalmol 2020;2020:1602739. [PMID: 32509339 DOI: 10.1155/2020/1602739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Grieger JC, Samulski RJ. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv Biochem Eng Biotechnol. 2005;99:119-145. [PMID: 16568890 DOI: 10.1007/10_005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
5 McCraw DM, O'Donnell JK, Taylor KA, Stagg SM, Chapman MS. Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20. Virology 2012;431:40-9. [PMID: 22682774 DOI: 10.1016/j.virol.2012.05.004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
6 Cearley CN, Wolfe JH. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol Ther 2006;13:528-37. [PMID: 16413228 DOI: 10.1016/j.ymthe.2005.11.015] [Cited by in Crossref: 253] [Cited by in F6Publishing: 221] [Article Influence: 16.9] [Reference Citation Analysis]
7 Kiyota T, Ingraham KL, Swan RJ, Jacobsen MT, Andrews SJ, Ikezu T. AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice. Gene Ther 2012;19:724-33. [PMID: 21918553 DOI: 10.1038/gt.2011.126] [Cited by in Crossref: 122] [Cited by in F6Publishing: 106] [Article Influence: 12.2] [Reference Citation Analysis]
8 Xiao X, Li J, Tsao YP, Dressman D, Hoffman EP, Watchko JF. Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy. J Virol 2000;74:1436-42. [PMID: 10627554 DOI: 10.1128/jvi.74.3.1436-1442.2000] [Cited by in Crossref: 78] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
9 Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S, Reier PJ, Mandel RJ, Muzyczka N. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 2004;10:302-17. [PMID: 15294177 DOI: 10.1016/j.ymthe.2004.05.024] [Cited by in Crossref: 515] [Cited by in F6Publishing: 468] [Article Influence: 32.2] [Reference Citation Analysis]
10 Lin LH, Dragon DN, Jin J, Talman WT. Targeting neurons of rat nucleus tractus solitarii with the gene transfer vector adeno-associated virus type 2 to up-regulate neuronal nitric oxide synthase. Cell Mol Neurobiol 2011;31:847-59. [PMID: 21431420 DOI: 10.1007/s10571-011-9674-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
11 Jennings K, Miyamae T, Traister R, Marinov A, Katakura S, Sowders D, Trapnell B, Wilson JM, Gao G, Hirsch R. Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo. Mol Ther 2005;11:600-7. [PMID: 15771962 DOI: 10.1016/j.ymthe.2004.10.020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
12 Gu�nard V, Schweitzer B, Flechsig E, Hemmi S, Martini R, Suter U, Schachner M. Effective gene transfer oflacZ andP0 into Schwann cells of P0-deficient mice. Glia 1999;25:165-78. [DOI: 10.1002/(sici)1098-1136(19990115)25:2<165::aid-glia7>3.0.co;2-l] [Cited by in Crossref: 23] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lo WD, Qu G, Sferra TJ, Clark R, Chen R, Johnson PR. Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of Expression. Human Gene Therapy 1999;10:201-13. [DOI: 10.1089/10430349950018995] [Cited by in Crossref: 136] [Cited by in F6Publishing: 118] [Article Influence: 6.2] [Reference Citation Analysis]
14 Robbins PD, Evans CH, Chernajovsky Y. Gene therapy for rheumatoid arthritis. Springer Semin Immunopathol 1998;20:197-209. [PMID: 9836377 DOI: 10.1007/BF00832007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
15 Ehrengruber MU. Alphaviral gene transfer in neurobiology. Brain Res Bull 2002;59:13-22. [PMID: 12372543 DOI: 10.1016/s0361-9230(02)00858-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
16 Bosch A, Perret E, Desmaris N, Heard JM. Long-Term and Significant Correction of Brain Lesions in Adult Mucopolysaccharidosis Type VII Mice Using Recombinant AAV Vectors. Molecular Therapy 2000;1:63-70. [DOI: 10.1006/mthe.1999.0005] [Cited by in Crossref: 92] [Cited by in F6Publishing: 83] [Article Influence: 4.4] [Reference Citation Analysis]
17 Lesch K. Gene transfer to the brain: emerging therapeutic strategy in psychiatry? Biological Psychiatry 1999;45:247-53. [DOI: 10.1016/s0006-3223(98)00236-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
18 Glatzel M, Flechsig E, Navarro B, Klein MA, Paterna JC, Büeler H, Aguzzi A. Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system. Proc Natl Acad Sci U S A 2000;97:442-7. [PMID: 10618437 DOI: 10.1073/pnas.97.1.442] [Cited by in Crossref: 91] [Cited by in F6Publishing: 73] [Article Influence: 4.3] [Reference Citation Analysis]
19 Cao G, Xiao M, Sun F, Xiao X, Pei W, Li J, Graham SH, Simon RP, Chen J. Cloning of a novel Apaf-1-interacting protein: a potent suppressor of apoptosis and ischemic neuronal cell death. J Neurosci 2004;24:6189-201. [PMID: 15240811 DOI: 10.1523/JNEUROSCI.1426-04.2004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
20 Wu P, Ye Y, Svendsen C. Transduction of human neural progenitor cells using recombinant adeno-associated viral vectors. Gene Ther 2002;9:245-55. [DOI: 10.1038/sj.gt.3301646] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
21 Cervelli T, Backovic A, Galli A. Formation of AAV single stranded DNA genome from a circular plasmid in Saccharomyces cerevisiae. PLoS One 2011;6:e23474. [PMID: 21853137 DOI: 10.1371/journal.pone.0023474] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
22 Hiraide A, Yokoo N, Xin KQ, Okuda K, Mizukami H, Ozawa K, Saito T. Repair of articular cartilage defect by intraarticular administration of basic fibroblast growth factor gene, using adeno-associated virus vector. Hum Gene Ther 2005;16:1413-21. [PMID: 16390272 DOI: 10.1089/hum.2005.16.1413] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
23 Keeler AM, Flotte TR. Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here? Annu Rev Virol 2019;6:601-21. [PMID: 31283441 DOI: 10.1146/annurev-virology-092818-015530] [Cited by in Crossref: 76] [Cited by in F6Publishing: 49] [Article Influence: 38.0] [Reference Citation Analysis]
24 Kao JH, Chen SL, Ma HI, Law PY, Tao PL, Loh HH. Intrathecal delivery of a mutant micro-opioid receptor activated by naloxone as a possible antinociceptive paradigm. J Pharmacol Exp Ther 2010;334:739-45. [PMID: 20554907 DOI: 10.1124/jpet.109.165399] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
25 Lentz TB, Samulski RJ. Insight into the mechanism of inhibition of adeno-associated virus by the Mre11/Rad50/Nbs1 complex. J Virol 2015;89:181-94. [PMID: 25320294 DOI: 10.1128/JVI.01990-14] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
26 Passini MA, Wolfe JH. Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector. J Virol 2001;75:12382-92. [PMID: 11711628 DOI: 10.1128/JVI.75.24.12382-12392.2001] [Cited by in Crossref: 120] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
27 Hauswirth WW, Lewin AS. Ribozyme uses in retinal gene therapy. Prog Retin Eye Res 2000;19:689-710. [PMID: 11029552 DOI: 10.1016/s1350-9462(00)00007-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
28 Rubin AD, Hogikyan ND, Sullivan K, Boulis N, Feldman EL. Remote delivery of rAAV-GFP to the rat brainstem through the recurrent laryngeal nerve. Laryngoscope 2001;111:2041-5. [PMID: 11801993 DOI: 10.1097/00005537-200111000-00032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
29 Lee B, Lee H, Nam YR, Oh JH, Cho YH, Chang JW. Enhanced expression of glutamate decarboxylase 65 improves symptoms of rat parkinsonian models. Gene Ther 2005;12:1215-22. [PMID: 15829994 DOI: 10.1038/sj.gt.3302520] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
30 Ly H, Kawase Y, Yoneyama R, Hajjar RJ. Gene Therapy in the Treatment of Heart Failure. Physiology 2007;22:81-96. [DOI: 10.1152/physiol.00037.2006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
31 Yokoo N, Saito T, Uesugi M, Kobayashi N, Xin K, Okuda K, Mizukami H, Ozawa K, Koshino T. Repair of articular cartilage defect by autologous transplantation of basic fibroblast growth factor gene-transduced chondrocytes with adeno-associated virus vector. Arthritis Rheum 2005;52:164-70. [DOI: 10.1002/art.20739] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
32 Surendran S, Matalon KM, Tyring SK, Matalon R. Molecular basis of Canavan's disease: from human to mouse. J Child Neurol 2003;18:604-10. [PMID: 14572138 DOI: 10.1177/08830738030180090601] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
33 Xu R, Janson CG, Mastakov M, Lawlor P, Young D, Mouravlev A, Fitzsimons H, Choi KL, Ma H, Dragunow M. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther. 2001;8:1323-1332. [PMID: 11571569 DOI: 10.1038/sj.gt.3301529] [Cited by in Crossref: 131] [Cited by in F6Publishing: 118] [Article Influence: 6.6] [Reference Citation Analysis]
34 Gwag BJ, Kim EY, Ryu BR, Won SJ, Ko HW, Oh YJ, Cho YG, Ha SJ, Sung YC. A neuron-specific gene transfer by a recombinant defective Sindbis virus. Brain Res Mol Brain Res 1998;63:53-61. [PMID: 9838041 DOI: 10.1016/s0169-328x(98)00251-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
35 Cheng L, Sapieha P, Kittlerova P, Hauswirth WW, Di Polo A. TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J Neurosci 2002;22:3977-86. [PMID: 12019317 DOI: 20026382] [Cited by in F6Publishing: 76] [Reference Citation Analysis]
36 Rosenberg JB, Kaminsky SM, Aubourg P, Crystal RG, Sondhi D. Gene therapy for metachromatic leukodystrophy. J Neurosci Res 2016;94:1169-79. [PMID: 27638601 DOI: 10.1002/jnr.23792] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 8.5] [Reference Citation Analysis]
37 Sohn J, Takahashi M, Okamoto S, Ishida Y, Furuta T, Hioki H. A Single Vector Platform for High-Level Gene Transduction of Central Neurons: Adeno-Associated Virus Vector Equipped with the Tet-Off System. PLoS One 2017;12:e0169611. [PMID: 28060929 DOI: 10.1371/journal.pone.0169611] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
38 Loeb JE, Cordier WS, Harris ME, Weitzman MD, Hope TJ. Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy. Hum Gene Ther 1999;10:2295-305. [PMID: 10515449 DOI: 10.1089/10430349950016942] [Cited by in Crossref: 189] [Cited by in F6Publishing: 156] [Article Influence: 8.6] [Reference Citation Analysis]
39 Hrabovska A, Duysen EG, Sanders JD, Murrin LC, Lockridge O. Delivery of human acetylcholinesterase by adeno-associated virus to the acetylcholinesterase knockout mouse. Chemico-Biological Interactions 2005;157-158:71-8. [DOI: 10.1016/j.cbi.2005.10.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
40 Tsai T, Chen S, Xiao X, Chiang Y, Lin S, Kuo S, Liu D, Tsao Y. Gene treatment of cerebral stroke by rAAV vector delivering IL-1ra in a rat model: . NeuroReport 2003;14:803-7. [DOI: 10.1097/00001756-200305060-00005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
41 Zhang H, Yang B, Mu X, Ahmed SS, Su Q, He R, Wang H, Mueller C, Sena-Esteves M, Brown R, Xu Z, Gao G. Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. Mol Ther 2011;19:1440-8. [PMID: 21610699 DOI: 10.1038/mt.2011.98] [Cited by in Crossref: 187] [Cited by in F6Publishing: 159] [Article Influence: 18.7] [Reference Citation Analysis]
42 Ehrengruber MU, Lundstrom K, Schweitzer C, Heuss C, Schlesinger S, Gähwiler BH. Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc Natl Acad Sci U S A 1999;96:7041-6. [PMID: 10359835 DOI: 10.1073/pnas.96.12.7041] [Cited by in Crossref: 120] [Cited by in F6Publishing: 112] [Article Influence: 5.5] [Reference Citation Analysis]
43 Bohne P, Schwarz MK, Herlitze S, Mark MD. A New Projection From the Deep Cerebellar Nuclei to the Hippocampus via the Ventrolateral and Laterodorsal Thalamus in Mice. Front Neural Circuits 2019;13:51. [PMID: 31447652 DOI: 10.3389/fncir.2019.00051] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
44 Cheng L, Sapieha P, Kittlerova P, Hauswirth WW, Di Polo A. TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J Neurosci 2002;22:3977-86. [PMID: 12019317 DOI: 20026382] [Cited by in Crossref: 160] [Article Influence: 8.4] [Reference Citation Analysis]
45 Zeng J, Too HP, Ma Y, Luo ES, Wang S. A synthetic peptide containing loop 4 of nerve growth factor for targeted gene delivery. J Gene Med 2004;6:1247-56. [PMID: 15368587 DOI: 10.1002/jgm.610] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
46 Cathomen T, Collete D, Weitzman MD. A chimeric protein containing the N terminus of the adeno-associated virus Rep protein recognizes its target site in an in vivo assay. J Virol 2000;74:2372-82. [PMID: 10666268 DOI: 10.1128/jvi.74.5.2372-2382.2000] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
47 Hauswirth WW, LaVail MM, Flannery JG, Lewin AS. Ribozyme gene therapy for autosomal dominant retinal disease. Clin Chem Lab Med 2000;38:147-53. [PMID: 10834402 DOI: 10.1515/CCLM.2000.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
48 Heider B, Nathanson JL, Isacoff EY, Callaway EM, Siegel RM. Two-photon imaging of calcium in virally transfected striate cortical neurons of behaving monkey. PLoS One 2010;5:e13829. [PMID: 21079806 DOI: 10.1371/journal.pone.0013829] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
49 Pietola L. Effects of p27 Kip1 - and p53- shRNAs on kanamycin damaged mouse cochlea. WJO 2012;2:1. [DOI: 10.5319/wjo.v2.i1.1] [Reference Citation Analysis]
50 Kiyota T, Yamamoto M, Schroder B, Jacobsen MT, Swan RJ, Lambert MP, Klein WL, Gendelman HE, Ransohoff RM, Ikezu T. AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP/PS1 mice. Mol Ther 2009;17:803-9. [PMID: 19277012 DOI: 10.1038/mt.2009.44] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
51 Burger C, Nguyen FN, Deng J, Mandel RJ. Systemic mannitol-induced hyperosmolality amplifies rAAV2-mediated striatal transduction to a greater extent than local co-infusion. Mol Ther 2005;11:327-31. [PMID: 15668145 DOI: 10.1016/j.ymthe.2004.08.031] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
52 Alisky JM, Davidson BL. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases. Hum Gene Ther 2000;11:2315-29. [PMID: 11096437 DOI: 10.1089/104303400750038435] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
53 Lee GK, Maheshri N, Kaspar B, Schaffer DV. PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization. Biotechnol Bioeng 2005;92:24-34. [PMID: 15937953 DOI: 10.1002/bit.20562] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 5.7] [Reference Citation Analysis]
54 Sollerbrant K, Elmén J, Wahlestedt C, Acker J, Leblois-prehaud H, Latta-mahieu M, Yeh P, Perricaudet M. A novel method using baculovirus-mediated gene transfer for production of recombinant adeno-associated virus vectors. Journal of General Virology 2001;82:2051-60. [DOI: 10.1099/0022-1317-82-9-2051] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
55 Zentilin L, Marcello A, Giacca M. Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome. J Virol 2001;75:12279-87. [PMID: 11711618 DOI: 10.1128/JVI.75.24.12279-12287.2001] [Cited by in Crossref: 78] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
56 Rolling F, Shen WY, Tabarias H, Constable I, Kanagasingam Y, Barry CJ, Rakoczy PE. Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography. Hum Gene Ther 1999;10:641-8. [PMID: 10094207 DOI: 10.1089/10430349950018715] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 1.8] [Reference Citation Analysis]
57 Yu JH, Schaffer DV. Advanced targeting strategies for murine retroviral and adeno-associated viral vectors. Adv Biochem Eng Biotechnol 2005;99:147-67. [PMID: 16568891 DOI: 10.1007/10_006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
58 Stone IM, Lurie DI, Kelley MW, Poulsen DJ. Adeno-associated virus-mediated gene transfer to hair cells and support cells of the murine cochlea. Mol Ther 2005;11:843-8. [PMID: 15922954 DOI: 10.1016/j.ymthe.2005.02.005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 3.4] [Reference Citation Analysis]
59 Sapieha PS, Peltier M, Rendahl KG, Manning WC, Di Polo A. Fibroblast growth factor-2 gene delivery stimulates axon growth by adult retinal ganglion cells after acute optic nerve injury. Mol Cell Neurosci 2003;24:656-72. [PMID: 14664816 DOI: 10.1016/s1044-7431(03)00228-8] [Cited by in Crossref: 85] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
60 Pernet V, Hauswirth WW, Di Polo A. Extracellular signal-regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo. J Neurochem 2005;93:72-83. [DOI: 10.1111/j.1471-4159.2005.03002.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
61 Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998;72:2224-32. [PMID: 9499080 DOI: 10.1128/JVI.72.3.2224-2232.1998] [Cited by in Crossref: 981] [Cited by in F6Publishing: 414] [Article Influence: 42.7] [Reference Citation Analysis]
62 Pouzolles M, Machado A, Guilbaud M, Irla M, Gailhac S, Barennes P, Cesana D, Calabria A, Benedicenti F, Sergé A, Raman I, Li QZ, Montini E, Klatzmann D, Adjali O, Taylor N, Zimmermann VS. Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells. J Allergy Clin Immunol 2020;145:679-697.e5. [PMID: 31513879 DOI: 10.1016/j.jaci.2019.08.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Senut MC, Suhr ST, Kaspar B, Gage FH. Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain. J Neurosci 2000;20:219-29. [PMID: 10627599 [PMID: 10627599 DOI: 10.1523/jneurosci.20-01-00219.2000] [Cited by in Crossref: 53] [Article Influence: 2.5] [Reference Citation Analysis]
64 Klein RL, Mandel RJ, Muzyczka N. Adeno-associated virus vector-mediated gene transfer to somatic cells in the central nervous system. Elsevier; 2000. pp. 507-28. [DOI: 10.1016/s0065-3527(00)55015-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
65 Trahair TN, Alexander IE, Rowe PB, Smythe JA. The adenovirus E4 ORF6 and E1b 55 kDa proteins cooperate in a p53-independent manner to enhance transduction by recombinant adeno-associated virus vectors. Journal of General Virology 2000;81:2983-91. [DOI: 10.1099/0022-1317-81-12-2983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
66 Ferrari FK, Xiao X, McCarty D, Samulski RJ. New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors. Nat Med 1997;3:1295-7. [PMID: 9359708 DOI: 10.1038/nm1197-1295] [Cited by in Crossref: 81] [Cited by in F6Publishing: 64] [Article Influence: 3.4] [Reference Citation Analysis]
67 Mastrangelo MA, Sudol KL, Narrow WC, Bowers WJ. Interferon-{gamma} differentially affects Alzheimer's disease pathologies and induces neurogenesis in triple transgenic-AD mice. Am J Pathol 2009;175:2076-88. [PMID: 19808651 DOI: 10.2353/ajpath.2009.090059] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
68 Williams RR, Pearse DD, Tresco PA, Bunge MB. The assessment of adeno-associated vectors as potential intrinsic treatments for brainstem axon regeneration. J Gene Med 2012;14:20-34. [PMID: 22106053 DOI: 10.1002/jgm.1628] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
69 Khalin I, Alyautdin R, Kocherga G, Bakar MA. Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness. Int J Nanomedicine 2015;10:3245-67. [PMID: 25995632 DOI: 10.2147/IJN.S77480] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
70 Paterna JC, Moccetti T, Mura A, Feldon J, Büeler H. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Ther. 2000;7:1304-1311. [PMID: 10918501 DOI: 10.1038/sj.gt.3301221] [Cited by in Crossref: 132] [Cited by in F6Publishing: 118] [Article Influence: 6.3] [Reference Citation Analysis]
71 Wu WC, Lai CC, Chen SL, Sun MH, Xiao X, Chen TL, Lin KK, Kuo SW, Tsao YP. Long-term safety of GDNF gene delivery in the retina. Curr Eye Res 2005;30:715-22. [PMID: 16109652 DOI: 10.1080/02713680591005922] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
72 Jooss K, Chirmule N. Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther 2003;10:955-63. [PMID: 12756416 DOI: 10.1038/sj.gt.3302037] [Cited by in Crossref: 208] [Cited by in F6Publishing: 174] [Article Influence: 11.6] [Reference Citation Analysis]
73 Ahmed BY, Chakravarthy S, Eggers R, Hermens WT, Zhang JY, Niclou SP, Levelt C, Sablitzky F, Anderson PN, Lieberman AR, Verhaagen J. Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors. BMC Neurosci 2004;5:4. [PMID: 15005815 DOI: 10.1186/1471-2202-5-4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 4.2] [Reference Citation Analysis]
74 Chen H, McCarty DM, Bruce AT, Suzuki K. Oligodendrocyte-specific gene expression in mouse brain: use of a myelin-forming cell type-specific promoter in an adeno-associated virus. J Neurosci Res 1999;55:504-13. [PMID: 10723060 DOI: 10.1002/(SICI)1097-4547(19990215)55:4<504::AID-JNR10>3.0.CO;2-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
75 Smith AD, Collaco RF, Trempe JP. Enhancement of recombinant adeno-associated virus type 2-mediated transgene expression in a lung epithelial cell line by inhibition of the epidermal growth factor receptor. J Virol 2003;77:6394-404. [PMID: 12743297 DOI: 10.1128/jvi.77.11.6394-6404.2003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
76 Shin S, Tuinstra HM, Salvay DM, Shea LD. Phosphatidylserine immobilization of lentivirus for localized gene transfer. Biomaterials 2010;31:4353-9. [PMID: 20206382 DOI: 10.1016/j.biomaterials.2010.02.013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
77 Mastakov MY, Baer K, Xu R, Fitzsimons H, During MJ. Combined injection of rAAV with mannitol enhances gene expression in the rat brain. Mol Ther. 2001;3:225-232. [PMID: 11237679 DOI: 10.1006/mthe.2001.0246] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 4.1] [Reference Citation Analysis]
78 Boison D. Inhibitory RNA in epilepsy: research tools and therapeutic perspectives. Epilepsia 2010;51:1659-68. [PMID: 20633035 DOI: 10.1111/j.1528-1167.2010.02672.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
79 Park HY, Kim JH, Sun Kim H, Park CK. Stem cell-based delivery of brain-derived neurotrophic factor gene in the rat retina. Brain Res 2012;1469:10-23. [PMID: 22750585 DOI: 10.1016/j.brainres.2012.06.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
80 Byrne PI, Collins S, Mah CC, Smith B, Conlon T, Martin SD, Corti M, Cleaver B, Islam S, Lawson LA. Phase I/II trial of diaphragm delivery of recombinant adeno-associated virus acid alpha-glucosidase (rAAaV1-CMV-GAA) gene vector in patients with Pompe disease. Hum Gene Ther Clin Dev 2014;25:134-63. [PMID: 25238277 DOI: 10.1089/humc.2014.2514] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
81 Di Benedetto B, Wefers B, Wurst W, Kühn R. Local knockdown of ERK2 in the adult mouse brain via adeno-associated virus-mediated RNA interference. Mol Biotechnol 2009;41:263-9. [PMID: 19052925 DOI: 10.1007/s12033-008-9125-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
82 Boulis NM, Noordmans AJ, Song DK, Imperiale MJ, Rubin A, Leone P, During M, Feldman EL. Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery. Neurobiol Dis 2003;14:535-41. [PMID: 14678769 DOI: 10.1016/j.nbd.2003.08.025] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
83 Kuklik J, Michelfelder S, Schiele F, Kreuz S, Lamla T, Müller P, Park JE. Development of a Bispecific Antibody-Based Platform for Retargeting of Capsid Modified AAV Vectors. Int J Mol Sci 2021;22:8355. [PMID: 34361120 DOI: 10.3390/ijms22158355] [Reference Citation Analysis]
84 Ioannou YA, Enriquez A, Benjamin C. Gene therapy for lysosomal storage disorders. Expert Opinion on Biological Therapy 2005;3:789-801. [DOI: 10.1517/14712598.3.5.789] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
85 Evans TA, Barkauskas DS, Silver J. Intravital imaging of immune cells and their interactions with other cell types in the spinal cord: Experiments with multicolored moving cells. Exp Neurol 2019;320:112972. [PMID: 31234058 DOI: 10.1016/j.expneurol.2019.112972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
86 Srivastava A, Rajappa M, Kaur J. Uveitis: Mechanisms and recent advances in therapy. Clinica Chimica Acta 2010;411:1165-71. [DOI: 10.1016/j.cca.2010.04.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
87 Watanabe S, Imagawa T, Boivin GP, Gao G, Wilson JM, Hirsch R. Adeno-Associated Virus Mediates Long-Term Gene Transfer and Delivery of Chondroprotective IL-4 to Murine Synovium. Molecular Therapy 2000;2:147-52. [DOI: 10.1006/mthe.2000.0111] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 3.5] [Reference Citation Analysis]
88 Moreau A, Vicente R, Dubreil L, Adjali O, Podevin G, Jacquet C, Deschamps JY, Klatzmann D, Cherel Y, Taylor N, Moullier P, Zimmermann VS. Efficient intrathymic gene transfer following in situ administration of a rAAV serotype 8 vector in mice and nonhuman primates. Mol Ther 2009;17:472-9. [PMID: 19088703 DOI: 10.1038/mt.2008.272] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
89 Pan RY, Xiao X, Chen SL, Li J, Lin LC, Wang HJ, Tsao YP. Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model. J Virol 1999;73:3410-7. [PMID: 10074195 DOI: 10.1128/JVI.73.4.3410-3417.1999] [Cited by in Crossref: 65] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
90 Lai CC, Wu WC, Chen SL, Sun MH, Xiao X, Ma L, Lin KK, Tsao YP. Recombinant adeno-associated virus vector expressing angiostatin inhibits preretinal neovascularization in adult rats. Ophthalmic Res 2005;37:50-6. [PMID: 15637422 DOI: 10.1159/000083040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
91 Grifman M, Chen NN, Gao GP, Cathomen T, Wilson JM, Weitzman MD. Overexpression of cyclin A inhibits augmentation of recombinant adeno-associated virus transduction by the adenovirus E4orf6 protein. J Virol 1999;73:10010-9. [PMID: 10559315 DOI: 10.1128/JVI.73.12.10010-10019.1999] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
92 Rolland A, Kareva T, Kholodilov N, Burke RE. A quantitative evaluation of a 2.5-kb rat tyrosine hydroxylase promoter to target expression in ventral mesencephalic dopamine neurons in vivo. Neuroscience 2017;346:126-34. [DOI: 10.1016/j.neuroscience.2017.01.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
93 Beck SE, Jones LA, Chesnut K, Walsh SM, Reynolds TC, Carter BJ, Askin FB, Flotte TR, Guggino WB. Repeated delivery of adeno-associated virus vectors to the rabbit airway. J Virol 1999;73:9446-55. [PMID: 10516053 DOI: 10.1128/JVI.73.11.9446-9455.1999] [Cited by in Crossref: 76] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
94 Kaspar BK, Erickson D, Schaffer D, Hinh L, Gage FH, Peterson DA. Targeted retrograde gene delivery for neuronal protection. Mol Ther 2002;5:50-6. [PMID: 11786045 DOI: 10.1006/mthe.2001.0520] [Cited by in Crossref: 120] [Cited by in F6Publishing: 105] [Article Influence: 6.3] [Reference Citation Analysis]
95 Tsai T, Chen S, Chiang Y, Lin S, Ma H, Kuo S, Tsao Y. Recombinant Adeno-Associated Virus Vector Expressing Glial Cell Line-Derived Neurotrophic Factor Reduces Ischemia-Induced Damage. Experimental Neurology 2000;166:266-75. [DOI: 10.1006/exnr.2000.7505] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.0] [Reference Citation Analysis]
96 Mastakov MY, Baer K, Kotin RM, During MJ. Recombinant adeno-associated virus serotypes 2- and 5-mediated gene transfer in the mammalian brain: quantitative analysis of heparin co-infusion. Mol Ther 2002;5:371-80. [PMID: 11945063 DOI: 10.1006/mthe.2002.0564] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
97 Kiyota T, Ingraham KL, Jacobsen MT, Xiong H, Ikezu T. FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders. Proc Natl Acad Sci U S A 2011;108:E1339-48. [PMID: 22042871 DOI: 10.1073/pnas.1102349108] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 7.5] [Reference Citation Analysis]
98 Grifman M, Trepel M, Speece P, Gilbert LB, Arap W, Pasqualini R, Weitzman MD. Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids. Mol Ther 2001;3:964-75. [PMID: 11407911 DOI: 10.1006/mthe.2001.0345] [Cited by in Crossref: 170] [Cited by in F6Publishing: 145] [Article Influence: 8.5] [Reference Citation Analysis]
99 Fraldi A, Hemsley K, Crawley A, Lombardi A, Lau A, Sutherland L, Auricchio A, Ballabio A, Hopwood JJ. Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes. Hum Mol Genet 2007;16:2693-702. [PMID: 17725987 DOI: 10.1093/hmg/ddm223] [Cited by in Crossref: 84] [Cited by in F6Publishing: 74] [Article Influence: 6.0] [Reference Citation Analysis]
100 Kwon I, Schaffer DV. Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer. Pharm Res. 2008;25:489-499. [PMID: 17763830 DOI: 10.1007/s11095-007-9431-0] [Cited by in Crossref: 105] [Cited by in F6Publishing: 85] [Article Influence: 7.5] [Reference Citation Analysis]
101 Shibata SB, Di Pasquale G, Cortez SR, Chiorini JA, Raphael Y. Gene transfer using bovine adeno-associated virus in the guinea pig cochlea. Gene Ther 2009;16:990-7. [PMID: 19458651 DOI: 10.1038/gt.2009.57] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
102 Eberling JL, Major EO, Nagy D, Bankiewicz KS. Genetic Engineering for Parkinson's Disease. CNS Regeneration. Elsevier; 1999. pp. 437-XII. [DOI: 10.1016/b978-012705070-6/50017-2] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
103 Tan EM, Yamaguchi Y, Horwitz GD, Gosgnach S, Lein ES, Goulding M, Albright TD, Callaway EM. Selective and quickly reversible inactivation of mammalian neurons in vivo using the Drosophila allatostatin receptor. Neuron 2006;51:157-70. [PMID: 16846851 DOI: 10.1016/j.neuron.2006.06.018] [Cited by in Crossref: 101] [Cited by in F6Publishing: 96] [Article Influence: 6.7] [Reference Citation Analysis]
104 Fitzsimons HL, Bland RJ, During MJ. Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain. Methods 2002;28:227-36. [DOI: 10.1016/s1046-2023(02)00227-x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
105 Tjin Tham Sjin RM, Naspinski J, Birsner AE, Li C, Chan R, Lo KM, Gillies S, Zurakowski D, Folkman J, Samulski J. Endostatin therapy reveals a U-shaped curve for antitumor activity. Cancer Gene Ther. 2006;13:619-627. [PMID: 16456550 DOI: 10.1038/sj.cgt.7700938] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
106 Liu Y, Keefe K, Tang X, Lin S, Smith GM. Use of self-complementary adeno-associated virus serotype 2 as a tracer for labeling axons: implications for axon regeneration. PLoS One 2014;9:e87447. [PMID: 24498323 DOI: 10.1371/journal.pone.0087447] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
107 Zhou Y, Pernet V, Hauswirth WW, Di Polo A. Activation of the Extracellular Signal-Regulated Kinase 1/2 Pathway by AAV Gene Transfer Protects Retinal Ganglion Cells in Glaucoma. Molecular Therapy 2005;12:402-12. [DOI: 10.1016/j.ymthe.2005.04.004] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 4.3] [Reference Citation Analysis]
108 Harris JA, Wook Oh S, Zeng H. Adeno‐Associated Viral Vectors for Anterograde Axonal Tracing with Fluorescent Proteins in Nontransgenic and Cre Driver Mice. Current Protocols in Neuroscience 2012;59. [DOI: 10.1002/0471142301.ns0120s59] [Cited by in Crossref: 27] [Cited by in F6Publishing: 44] [Article Influence: 3.0] [Reference Citation Analysis]
109 Rattazzi MC, Dobrenis K. Treatment of GM2 gangliosidosis: past experiences, implications, and future prospects. Adv Genet 2001;44:317-39. [PMID: 11596993 DOI: 10.1016/s0065-2660(01)44089-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Fleming J, Ginn SL, Weinberger RP, Trahair TN, Smythe JA, Alexander IE. Adeno-associated virus and lentivirus vectors mediate efficient and sustained transduction of cultured mouse and human dorsal root ganglia sensory neurons. Hum Gene Ther 2001;12:77-86. [PMID: 11177545 DOI: 10.1089/104303401450997] [Cited by in Crossref: 56] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
111 Penrod RD, Wells AM, Carlezon WA Jr, Cowan CW. Use of Adeno-Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice. Curr Protoc Neurosci 2015;73:4.37.1-4.37.31. [PMID: 26426386 DOI: 10.1002/0471142301.ns0437s73] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
112 Ciron C, Cressant A, Roux F, Raoul S, Cherel Y, Hantraye P, Déglon N, Schwartz B, Barkats M, Heard J, Tardieu M, Moullier P, Colle M. Human α-Iduronidase Gene Transfer Mediated by Adeno-Associated Virus Types 1, 2, and 5 in the Brain of Nonhuman Primates: Vector Diffusion and Biodistribution. Human Gene Therapy 2009;20:350-60. [DOI: 10.1089/hum.2008.155] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
113 Ly HQ, Kawase Y, Hajjar RJ. Advances in gene-based therapy for heart failure. J Cardiovasc Transl Res 2008;1:127-36. [PMID: 20559907 DOI: 10.1007/s12265-008-9022-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
114 Castle MJ, Gershenson ZT, Giles AR, Holzbaur EL, Wolfe JH. Adeno-associated virus serotypes 1, 8, and 9 share conserved mechanisms for anterograde and retrograde axonal transport. Hum Gene Ther 2014;25:705-20. [PMID: 24694006 DOI: 10.1089/hum.2013.189] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 10.6] [Reference Citation Analysis]
115 Dominiczak AF, Negrin DC, Clark JS, Brosnan MJ, Mcbride MW, Alexander MY. Genes and Hypertension: From Gene Mapping in Experimental Models to Vascular Gene Transfer Strategies. Hypertension 2000;35:164-72. [DOI: 10.1161/01.hyp.35.1.164] [Cited by in Crossref: 68] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
116 Gagliardi C, Bunnell BA. Large animal models of neurological disorders for gene therapy. ILAR J 2009;50:128-43. [PMID: 19293458 DOI: 10.1093/ilar.50.2.128] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
117 Chamberlin NL, Du B, de Lacalle S, Saper CB. Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS. Brain Res 1998;793:169-75. [PMID: 9630611 DOI: 10.1016/s0006-8993(98)00169-3] [Cited by in Crossref: 159] [Cited by in F6Publishing: 82] [Article Influence: 7.2] [Reference Citation Analysis]
118 Rabinowitz JE, Samulski J. Adeno-associated virus expression systems for gene transfer. Current Opinion in Biotechnology 1998;9:470-5. [DOI: 10.1016/s0958-1669(98)80031-1] [Cited by in Crossref: 107] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
119 Hernandez YJ, Wang J, Kearns WG, Loiler S, Poirier A, Flotte TR. Latent Adeno-Associated Virus Infection Elicits Humoral but Not Cell-Mediated Immune Responses in a Nonhuman Primate Model. J Virol 1999;73:8549-58. [DOI: 10.1128/jvi.73.10.8549-8558.1999] [Cited by in Crossref: 126] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
120 Michelfelder S, Trepel M. Adeno-associated viral vectors and their redirection to cell-type specific receptors. Adv Genet 2009;67:29-60. [PMID: 19914449 DOI: 10.1016/S0065-2660(09)67002-4] [Cited by in Crossref: 77] [Cited by in F6Publishing: 54] [Article Influence: 7.0] [Reference Citation Analysis]
121 Castle MJ, Perlson E, Holzbaur EL, Wolfe JH. Long-distance axonal transport of AAV9 is driven by dynein and kinesin-2 and is trafficked in a highly motile Rab7-positive compartment. Mol Ther 2014;22:554-66. [PMID: 24100640 DOI: 10.1038/mt.2013.237] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
122 Nguyen JB, Sanchez-Pernaute R, Cunningham J, Bankiewicz KS. Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain. Neuroreport 2001;12:1961-4. [PMID: 11435930 DOI: 10.1097/00001756-200107030-00037] [Cited by in Crossref: 101] [Cited by in F6Publishing: 78] [Article Influence: 5.1] [Reference Citation Analysis]
123 Howard DB, Powers K, Wang Y, Harvey BK. Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro. Virology 2008;372:24-34. [PMID: 18035387 DOI: 10.1016/j.virol.2007.10.007] [Cited by in Crossref: 92] [Cited by in F6Publishing: 88] [Article Influence: 6.6] [Reference Citation Analysis]
124 Callaway EM. A molecular and genetic arsenal for systems neuroscience. Trends Neurosci 2005;28:196-201. [PMID: 15808354 DOI: 10.1016/j.tins.2005.01.007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 4.2] [Reference Citation Analysis]
125 D'onofrio PM, Thayapararajah M, Lysko MD, Magharious M, Spratt SK, Lee G, Ando D, Surosky R, Fehlings MG, Koeberle PD. Gene Therapy for Traumatic Central Nervous System Injury and Stroke Using an Engineered Zinc Finger Protein that Upregulates VEGF-A. Journal of Neurotrauma 2011;28:1863-79. [DOI: 10.1089/neu.2011.1896] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]